🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/01/2010 | 55,73 | 57,25 | 55,55 | 56,63 | +1,61% | 3,05% | 718.500 |
| 12/01/2010 | 54,44 | 55,90 | 54,03 | 55,73 | +1,75% | 3,43% | 608.200 |
| 11/01/2010 | 55,00 | 55,69 | 54,69 | 54,77 | -0,09% | 1,82% | 605.200 |
| 08/01/2010 | 55,40 | 55,66 | 54,54 | 54,82 | -1,17% | 2,02% | 460.700 |
| 07/01/2010 | 53,22 | 55,47 | 53,20 | 55,47 | +2,53% | 4,27% | 1.171.700 |
| 06/01/2010 | 53,38 | 54,18 | 53,28 | 54,10 | +1,56% | 1,69% | 565.700 |
| 05/01/2010 | 53,54 | 54,12 | 53,07 | 53,27 | -0,32% | 1,96% | 516.500 |
| 04/01/2010 | 52,88 | 54,05 | 52,46 | 53,44 | +1,50% | 3,01% | 654.100 |
| 31/12/2009 | 52,60 | 52,91 | 51,96 | 52,65 | +0,42% | 1,81% | 312.100 |
| 30/12/2009 | 52,47 | 52,96 | 52,04 | 52,43 | -0,42% | 1,75% | 303.900 |
| 29/12/2009 | 52,89 | 52,99 | 52,25 | 52,65 | -0,28% | 1,40% | 164.400 |
| 28/12/2009 | 53,00 | 53,00 | 52,63 | 52,80 | +0,08% | 0,70% | 399.700 |
| 24/12/2009 | 53,00 | 53,00 | 52,47 | 52,76 | -0,23% | 1,00% | 71.400 |
| 23/12/2009 | 52,78 | 53,57 | 52,61 | 52,88 | +0,08% | 1,82% | 368.300 |
| 22/12/2009 | 51,60 | 52,98 | 51,60 | 52,84 | +2,32% | 2,67% | 782.400 |
| 21/12/2009 | 52,02 | 52,39 | 51,37 | 51,64 | -0,73% | 1,96% | 1.039.400 |
| 18/12/2009 | 52,40 | 53,50 | 51,93 | 52,02 | -0,04% | 3,00% | 1.215.900 |
| 17/12/2009 | 50,28 | 52,79 | 50,06 | 52,04 | +3,42% | 5,43% | 1.699.100 |
| 16/12/2009 | 47,25 | 51,00 | 47,25 | 50,32 | +6,75% | 7,94% | 1.656.600 |
| 15/12/2009 | 46,75 | 47,20 | 46,50 | 47,14 | +0,13% | 1,50% | 443.200 |
| 14/12/2009 | 46,74 | 47,27 | 46,51 | 47,08 | +0,81% | 1,63% | 364.000 |
| 11/12/2009 | 46,35 | 46,93 | 46,35 | 46,70 | +0,76% | 1,25% | 366.800 |
| 10/12/2009 | 45,44 | 46,42 | 45,16 | 46,35 | +2,36% | 2,77% | 345.200 |
| 09/12/2009 | 44,37 | 45,44 | 44,06 | 45,28 | +1,91% | 3,11% | 278.100 |
| 08/12/2009 | 44,64 | 45,09 | 44,35 | 44,43 | -0,67% | 1,66% | 325.400 |
| 07/12/2009 | 45,06 | 45,52 | 44,40 | 44,73 | -1,02% | 2,49% | 263.700 |
| 04/12/2009 | 45,72 | 46,33 | 44,65 | 45,19 | -0,22% | 3,67% | 807.600 |
| 03/12/2009 | 46,23 | 46,49 | 45,19 | 45,29 | -1,93% | 2,81% | 281.400 |
| 02/12/2009 | 45,66 | 46,65 | 45,49 | 46,18 | +0,76% | 2,54% | 359.700 |
| 01/12/2009 | 45,81 | 46,03 | 45,58 | 45,83 | +0,53% | 0,98% | 274.400 |